Form 4 for CGTX COGNITION THERAPEUTICS INC
Accepted 2023-02-07 00:00:00 ET · period of report 2023-02-03 · accession 0000899243-23-004184 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-07 | 2023-02-03 | CGTX | Caggiano Anthony | Chief Medical Off | A - Grant | $0.00 | +94.4K | 94.4K | New | $0 |
| D | 2023-02-07 | 2023-02-03 | CGTX | Caggiano Anthony | Chief Medical Off | A - Grant | $0.00 | +94.4K | 94.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-03 | A | A | 94,406 | $0.00 | 94,406 | D | — | — | (F1) Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-02-03 | A | A | 94,406 | $0.00 | 94,406 | D | $2.12 · — to 2033-02-03 | 94,406 Common Stock | (F2) The option vests 33.3% on February 3, 2024, with the remaining 66.7% vesting in 24 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates. |